AcquisitionOther
InMed Pharmaceuticals, Inc. acquired Mentari Therapeutics, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
InMed Pharmaceuticals, Inc. -> Mentari Therapeutics, Inc. · US$290 million
Brings together Mentari's differentiated migraine pipeline with InMed's public market infrastructure
Open source record (SEC) ↗